This recognition highlights the excellence of Cressey & Company in implementing distinctive practices in due diligence , value creation, modern internal operations, and family business culture. The rigorous and independent selection process evaluated more than 6,000 firms based on 75 criteria and over 400,000 data points, in consultation with institutional investors, investment bankers, and industry experts. This list of criteria aligns well with BluWave’s DNA, an expert platform that connects private equity firms with specialized service providers to accelerate value creation, optimize due diligence, and professionalize operations.
Founded over 40 years ago, the Fund manager one of the first of its kind in the United States. It specializes in investments targeting the healthcare and information technology sectors. With $3.7 billion in assets under management, the firm has established partnerships with more than 35 companies, focusing on proven business models and significant growth prospects. Cressey & Company approach, summarized by the principles “Target, Partner, Build,” consists of identifying high-potential segments, collaborating closely with experienced management teams, and building innovative and sustainable companies in the healthcare sector.













